上海药明生物技术有限公司 Wuxi Biologics
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
WuXi Biologics' Chief Executive Officer Dr. Chris Chen to Serve on Board of Directors at ISPE and Delivered Keynote Speech at 2018 Annual Meeting 2018-11-07 17:51
WuXi Biologics Commenced Construction of 48,000L Biologics Commercial Manufacturing Center in Shijiazhuang 2018-10-31 16:08
WuXi Biologics Congratulates Tychan on Completing Human Safety Studies for the First-in-Class Zika Virus Antibody in Record Speed 2018-10-29 20:10
CANbridge Pharmaceutical and WuXi Biologics Enter into Strategic Partnership for Rare Disease Therapeutics 2018-10-23 20:00
I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Three Bispecific Antibody Programs 2018-09-26 19:24
WuXi Biologics Appoints Harvard Professor David R. Liu to Scientific Advisory Board 2018-09-25 08:00
WuXi Biologics Appoints Harvard Professor David R. Liu to Scientific Advisory Board 2018-09-25 08:00
WuXi Biologics' Chief Quality Officer Received Foreign Post Service Award from FDA 2018-09-18 08:08
WuXi Biologics and Inhibrx Enter an Exclusive Partnership for GMP Manufacturing 2018-09-11 08:38
WuXi Biologics Selected into the Hang Seng HK 35 Index 2018-08-30 10:08
WuXi Biologics Reports Robust 2018 Interim Results 2018-08-20 20:25
WuXi Biologics Commenced Process Validation in MFG2 2018-07-31 07:55
WuXi Biologics Announced Successful Completion of the First cGMP Run in MFG3 2018-07-25 07:55
WuXi Biologics and Immune Pharmaceuticals Announce Late-Phase Development and Manufacturing Partnership for a First-In-Class Monoclonal Antibody 2018-07-09 22:00
WuXi Biologics and Harbour BioMed Announce Strategic Development and Manufacturing Partnership 2018-06-25 07:55
WuXi Biologics Initiated Construction of a State-of-the-Art Integrated ADC Solution Center 2018-06-20 08:03
WuXi Biologics to Invest $60 Million to Establish a Biologics Production Facility in the United States 2018-06-11 08:34
WuXi Biologics and Tsinghua University Innovation Center for Immune Therapy Sign MOU and Announce Strategic Partnership 2018-05-30 08:34
WuXi Biologics to Invest S$80 Million to Establish a Biologics Manufacturing Facility in Singapore 2018-05-22 18:34
WuXi Biologics and Bioasis Announce Initial Strategic Collaboration for the Development and Manufacturing of Bioasis' Lead Investigational Candidate to Treat Brain Cancer 2018-05-21 20:30
1 6 7 8 9 10